Hematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousHematopoietic Stem CellsGraft vs Host DiseaseTransplantation, AutologousStem Cell TransplantationTransplantation ConditioningBone MarrowBone Marrow CellsHematologic NeoplasmsTransplantation ChimeraWhole-Body IrradiationPeripheral Blood Stem Cell TransplantationStem CellsTissue DonorsGraft SurvivalLeukemiaBusulfanLiver TransplantationHistocompatibility TestingTreatment OutcomeHistocompatibilityHematopoiesisAnemia, AplasticRecurrenceCord Blood Stem Cell TransplantationCombined Modality TherapyRetrospective StudiesRemission InductionCyclophosphamideImmunosuppressive AgentsHematopoietic Stem Cell MobilizationKidney TransplantationGraft vs Leukemia EffectLeukemia, Myeloid, AcuteTransplantation, IsogeneicAntigens, CD34Hepatic Veno-Occlusive DiseaseMyeloablative AgonistsTime FactorsBone and BonesMice, Inbred C57BLChimerismHematologic DiseasesCell DifferentiationHLA AntigensTransplantation ImmunologyMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival AnalysisSevere Combined ImmunodeficiencySurvival RateMultiple MyelomaBone Marrow PurgingDisease-Free SurvivalGraft RejectionGraft vs Tumor EffectLymphocyte TransfusionColony-Forming Units AssayCell TransplantationMesenchymal Stem Cell TransplantationLymphocyte DepletionMelphalanFlow CytometryAcute DiseaseAntineoplastic Combined Chemotherapy ProtocolsLymphoma, Non-HodgkinImmunosuppressionT-LymphocytesCell LineageBone Marrow DiseasesLeukemia, MyeloidGranulocyte Colony-Stimulating FactorHeart TransplantationCytomegalovirus InfectionsSiblingsFollow-Up StudiesRadiation ChimeraVidarabineUnrelated DonorsAntilymphocyte SerumLung TransplantationSalvage TherapyOrgan TransplantationCells, CulturedMedical OncologyCytarabineFetal BloodStem Cell NichePrognosisCyclosporineCell SeparationOpportunistic InfectionsEmbryonic Stem CellsAdult Stem CellsLeukocyte TransfusionTransplantationImmunocompromised Host